In the latest trading session, 4.65 million BriaCell Therapeutics Corp (NASDAQ:BCTX) shares changed hands as the company’s beta touched 1.34. With the company’s most recent per share price at $0.85 changing hands around $0.05 or 6.77% at last look, the market valuation stands at $30.47M. BCTX’s current price is a discount, trading about -602.35% off its 52-week high of $5.97. The share price had its 52-week low at $0.46, which suggests the last value was 45.88% up since then. When we look at BriaCell Therapeutics Corp’s average trading volume, we note the 10-day average is 1.4 million shares, with the 3-month average coming to 4.67 million.
BriaCell Therapeutics Corp (NASDAQ:BCTX) trade information
Instantly BCTX is in green as seen in intraday trades today. With action -5.51%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -85.47%, with the 5-day performance at -5.51% in the red. However, in the 30-day time frame, BriaCell Therapeutics Corp (NASDAQ:BCTX) is 24.61% up. Looking at the short shares, we see there were 0.45 million shares sold at short interest cover period of 0.04 days.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
BriaCell Therapeutics Corp (BCTX) estimates and forecasts
Data shows that the BriaCell Therapeutics Corp share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -63.36% over the past 6 months, a 38.46% in annual growth rate that is considerably higher than the industry average of 17.20%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 32.71%. The 2024 estimates are for BriaCell Therapeutics Corp earnings to increase by 16.92%.
BCTX Dividends
BriaCell Therapeutics Corp is expected to release its next quarterly earnings report on 2024-Oct-23.
BriaCell Therapeutics Corp (NASDAQ:BCTX)’s Major holders
With 7.23 shares estimated at $6062.0 under it, the former controlled 0.02% of total outstanding shares.
